SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

2.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

3.

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

4.

Oncology Drug Shortages Persist, but Continue to Evolve

5.

Cancerous breast tissue glows in new AI-enhanced MRI images


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot